{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:45:06Z","timestamp":1785883506060,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["JCZRQN202500725"],"award-info":[{"award-number":["JCZRQN202500725"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303188"],"award-info":[{"award-number":["82303188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203802"],"award-info":[{"award-number":["82203802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119573","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:27:31Z","timestamp":1781270851000},"page":"119573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis"],"prefix":"10.1016","volume":"201","author":[{"given":"Mengzhen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-3379","authenticated-orcid":false,"given":"Dong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henghui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119573_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastro Hepat."},{"key":"10.1016\/j.biopha.2026.119573_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jhep.2023.05.010","article-title":"Immunobiology of cholangiocarcinoma","volume":"79","author":"Tomlinson","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119573_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"Ca-Cancer J. Clin."},{"key":"10.1016\/j.biopha.2026.119573_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119573_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2026.119573_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119573_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119573_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119573_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119573_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tibs.2014.03.001","article-title":"Heparan sulfate signaling in cancer","volume":"39","author":"Knelson","year":"2014","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.biopha.2026.119573_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fonc.2014.00195","article-title":"The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics","volume":"4","author":"Hammond","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119573_bib12","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1021\/jacs.0c00005","article-title":"Trisaccharide sulfate and its sulfonamide as an effective substrate and inhibitor of human endo-O-sulfatase-1","volume":"142","author":"Chiu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119573_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/1541-7786.MCR-14-0372","article-title":"Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases","volume":"13","author":"Vicente","year":"2015","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119573_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/hep.27658","article-title":"Activation of the transforming growth factor-beta\/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma","volume":"61","author":"Dhanasekaran","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119573_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.22202","article-title":"Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma","volume":"47","author":"Lai","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119573_bib16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood.2020008188","article-title":"Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis","volume":"137","author":"Ren","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119573_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.biopha.2017.03.017","article-title":"Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1\/2 pathways","volume":"89","author":"Tao","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119573_bib18","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/sj.onc.1210300","article-title":"Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance","volume":"26","author":"Staub","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119573_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13046-015-0141-x","article-title":"SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells","volume":"34","author":"Vicente","year":"2015","journal-title":"J. Exp. Clin. Canc Res."},{"key":"10.1016\/j.biopha.2026.119573_bib20","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/hep.23848","article-title":"The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation","volume":"52","author":"Lai","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119573_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.semcancer.2021.12.011","article-title":"Multifaceted role of chemokines in solid tumors: From biology to therapy","volume":"86","author":"Raza","year":"2022","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.biopha.2026.119573_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12943-022-01653-2","article-title":"The FUS\/circEZH2\/KLF5\/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119573_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2012.06.012","article-title":"Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma","volume":"57","author":"Gentilini","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119573_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-014-0103-8","article-title":"Blockade of CXCL12\/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway","volume":"33","author":"Zhao","year":"2014","journal-title":"J. Exp. Clin. Canc Res."},{"key":"10.1016\/j.biopha.2026.119573_bib25","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.7150\/thno.26506","article-title":"Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness","volume":"8","author":"Xie","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119573_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-016-0348-0","article-title":"LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner","volume":"9","author":"Wang","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2026.119573_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cdd.2013.13","article-title":"Targeting the Y\/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?","volume":"20","author":"Dolfini","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2026.119573_bib28","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/cas.14006","article-title":"Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer","volume":"110","author":"Kuwano","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2026.119573_bib29","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-22-0991","article-title":"CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization","volume":"28","author":"Hong","year":"2022","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119573_bib30","article-title":"Extracellular endosulfatase Sulf-2 harbors a chondroitin\/dermatan sulfate chain that modulates its enzyme activity","volume":"38","author":"El","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119573_bib31","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/hep.31817","article-title":"Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling Axis","volume":"74","author":"Luo","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119573_bib32","article-title":"Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy","volume":"5","author":"Dheeraj","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2026.119573_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.62347\/RXVE7097","article-title":"6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets","volume":"14","author":"Han","year":"2024","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119573_bib34","article-title":"Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm","volume":"1877","author":"Nengroo","year":"2022","journal-title":"Bba-Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119573_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.gendis.2015.05.001","article-title":"Role of post-translational modification of the Y box binding protein 1 in human cancers","volume":"2","author":"Prabhu","year":"2015","journal-title":"Genes Dis."},{"key":"10.1016\/j.biopha.2026.119573_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbrc.2016.10.107","article-title":"Transportin-1-dependent YB-1 nuclear import","volume":"480","author":"Mordovkina","year":"2016","journal-title":"Biochem Bioph Res Co."},{"key":"10.1016\/j.biopha.2026.119573_bib37","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.32483","article-title":"Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2026.119573_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","article-title":"Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription","volume":"76","author":"Chen","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2026.119573_bib39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","article-title":"KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-kappaB pathway in cholangiocarcinoma","volume":"42","author":"Jiang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119573_bib40","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/liv.15240","article-title":"m(5) C and m(6) A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR-582-3p-YAP1 axis","volume":"42","author":"Zheng","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2026.119573_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct. Tar."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:54:28Z","timestamp":1785880468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S0753332226006098"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119573","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119573"}}